Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 9974
Country/Region: Vietnam
Year: 2015
Main Partner: Ho Chi Minh City Provincial AIDS Committee
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $2,200,000 Additional Pipeline Funding: $1,017,861

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $175,000
Care: TB/HIV (HVTB) $100,000
Care: Pediatric Care and Support (PDCS) $20,000
Laboratory Infrastructure (HLAB) $100,000
Strategic Information (HVSI) $150,000
Testing: HIV Testing and Counseling (HVCT) $200,000
Sexual Prevention: Other Sexual Prevention (HVOP) $100,000
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $105,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $110,000
Treatment: Adult Treatment (HTXS) $1,050,000
Treatment: Pediatric Treatment (PDTX) $90,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 650
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 673
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 3,773
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 7,768
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 12,864
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 12,864
CARE_NEW Aggregated Age/sex: <15 Female 2016 30
CARE_NEW Aggregated Age/sex: <15 Male 2016 62
CARE_NEW Aggregated Age/sex: 15+ Female 2016 291
CARE_NEW Aggregated Age/sex: 15+ Male 2016 655
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 1,038
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 1,038
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 1,038
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 293
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 293
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 78,880
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 3,188
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 7,420
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 15,803
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 86,886
HTS_TST Sum of Aggregated Age/Sex <15 2016 586
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 15,803
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 86,300
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 15,803
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 86,886
KP_MAT Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months 2016 1,050
KP_MAT Sex: Female 2016 54
KP_MAT Sex: Male 2016 996
KP_MAT Sum of Sex disaggregates 2016 1,050
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 5,191
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 280
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 5,264
KP_PREV By key population type: Men who have sex with men/Transgender (MSM/TG) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 1,152
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2016 11,886
LAB_CAP By clinical laboratories 2016 12
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 12
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 594
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 553
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 222
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 331
PMTCT_ARV Sum of New and Current disaggregates 2016 553
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 586
PMTCT_STAT By: Known positives at entry 2016 451
PMTCT_STAT By: Number of new positives identified 2016 143
PMTCT_STAT Number of new ANC and L&D clients 2016 7,100
PMTCT_STAT Number of new ANC and L&D clients 2016 124,700
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 7,100
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 124,700
PMTCT_STAT Sum of Positives Status disaggregates 2016 594
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 1,295
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 11,313
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 12,864
TB_SCREEN Sum of Aggregated Age disaggregates 2016 12,608
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 12,608
TX_CURR Aggregated Age/Sex: <1 Female 2016 6
TX_CURR Aggregated Age/Sex: <1 Male 2016 14
TX_CURR Aggregated Age/Sex: 15+ Female 2016 3,625
TX_CURR Aggregated Age/Sex: 15+ Male 2016 7,598
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 12,489
TX_CURR Sum of Aggregated Age/Sex (<1 and 1-14) <15 2016 1,266
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 11,223
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 11,223
TX_NEW Aggregated Grouping by Age: <1 Male 2016 14
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2016 4
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 292
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 574
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 958
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 866
Cross Cutting Budget Categories and Known Amounts Total: $5
Human Resources for Health $1
Key Populations: Sex Workers $1
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Conducting epidemiologic, social science, and operational research among SWs, their partners, and clients
Monitoring and evaluation of SW programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for SWs
Key Populations: MSM and TG $1
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Education $1
Condoms: Commodities $1